ArticleFrontiers in veterinary science2025
Non-linear pharmacokinetics of penciclovir in healthy cats after single and multiple oral administration of famciclovir.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Feline Infectious Rhinobronchitis (FVR) is a common and serious infectious upper respiratory disease. Famciclovir, an antiviral prodrug initially developed for human herpesviruses, demonstrates significant therapeutic efficacy in cats with FVR caused by feline herpesvirus type 1 (FHV-1). Methods: To determine the pharmacokinetics of famciclovir in healthy cats after single or multiple oral and intravenous administrations-40 cats in 4 different dose groups received famciclovir through a single oral dose, while 10 cats received famciclovir every 12 h for 14 days, and another 10 cats received a single intravenous dose of penciclovir-in three different phases. At the predetermined time points, blood samples were collected through the radial vein of the cat. The blood samples were analyzed by liquid chromatography-tandem mass spectrometry to detect the concentration of penciclovir in cat plasma. The pharmacokinetic parameters of penciclovir were calculated using a noncompartmental model. Results: After a single oral administration in cats, the absorption and exposure of famciclovir tablets also increased with the increase in dose. After multiple oral administrations of famciclovir tablets, the concentration of the drug fluctuated violently in steady state with no accumulation in the body. The absolute bioavailability of the tested cats after single oral administration of 15.625 g, 31.25, 62.5, and 93.75 mg/kg famciclovir tablets was 67.12, 33.94, 26.45, and 18.37%, respectively. Discussion: In summary, after oral administration in cats, the absorption and exposure of famciclovir tablets showed overall non-linear pharmacokinetic characteristics. This study provides a scientific basis for the clinical dosage and duration of treatment of FVR with famciclovir tablets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.